2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
暂无分享,去创建一个
A. Khera | Sidney C. Smith | D. Lloyd‐Jones | Z. Goldberger | J. McEvoy | R. Blumenthal | D. Arnett | J. Yeboah | K. Williams | S. Virani | E. Michos | E. Hahn | B. Ziaeian | M. Albert | Andrew B. Buroker | C. Himmelfarb | M. Miedema | Daniel Muñoz | Michelle A. Albert | Amit Khera | Erin D Michos | D. Muñoz | Donna K. Arnett | Donald M. Lloyd-Jones | Michelle A. Albert | Ellen J. Hahn | Cheryl Dennison Himmelfarb | J. William McEvoy | Sidney C. Smith | Salim S Virani | Kim A. Williams | Joseph Yeboah | Donald M Lloyd-Jones | Erin D. Michos | Joseph Yeboah | Salim S. Virani
[1] Daniel E Forman,et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.
[2] Deepak L. Bhatt,et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019, The New England journal of medicine.
[3] Marc P. Bonaca,et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials , 2019, The Lancet.
[4] N. Rigotti,et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2018, Journal of the American College of Cardiology.
[5] L. Shaw,et al. Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring. , 2018, Journal of the American College of Cardiology.
[6] D. Mozaffarian,et al. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study , 2018, The Lancet.
[7] D. Reboussin,et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Circulation.
[8] R. Collins,et al. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus , 2018, The New England journal of medicine.
[9] P. Ridker. Should Aspirin Be Used for Primary Prevention in the Post-Statin Era? , 2018, The New England journal of medicine.
[10] Diane M. Miller,et al. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. , 2018, Lancet.
[11] P. Barbillon,et al. Patterns of plant and animal protein intake are strongly associated with cardiovascular mortality: the Adventist Health Study-2 cohort. , 2018, International journal of epidemiology.
[12] Carrie D. Patnode,et al. Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.
[13] Suzanne G. Orchard,et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly , 2018, The New England journal of medicine.
[14] L. Tokgozoglu,et al. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. , 2018, Journal of the American College of Cardiology.
[15] P. Rothwell,et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial , 2018, The Lancet.
[16] Samia Mora,et al. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative , 2018, JAMA internal medicine.
[17] Jennifer J. Otten,et al. Low-Calorie Sweetened Beverages and Cardiometabolic Health: A Science Advisory From the American Heart Association , 2018, Circulation.
[18] E. Rimm,et al. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis , 2018, The Lancet. Public health.
[19] V. Fuster,et al. Cardiovascular Health Promotion: An Issue That Can No Longer Wait. , 2018, Journal of the American College of Cardiology.
[20] N. Cook,et al. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials , 2018, The Lancet.
[21] P. Greenland,et al. Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events. , 2018, Circulation.
[22] J. Ige,et al. Built and natural environment planning principles for promoting health: an umbrella review , 2018, BMC Public Health.
[23] M. Paasche-Orlow,et al. Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association. , 2018, Circulation.
[24] K. Watson,et al. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. , 2018, Circulation.
[25] D. Mozaffarian,et al. Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association , 2018, Circulation.
[26] R. Kronmal,et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) , 2018, European heart journal.
[27] M. Hernán,et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.
[28] S. Basu,et al. Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk , 2018, Annals of Internal Medicine.
[29] J. Manson,et al. Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes Mellitus. , 2018, Journal of the American College of Cardiology.
[30] Dustin M. Thomas,et al. Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk‐management gaps among a primary‐prevention population compared with a propensity‐matched primary‐care cohort: A team‐based care model and its impact on lip , 2018, Clinical cardiology.
[31] David M. Reboussin,et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Hypertension.
[32] R. D'Agostino,et al. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection , 2018, Circulation.
[33] A. Perzynski,et al. Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position , 2018, Annals of Internal Medicine.
[34] S. Stavrakis,et al. Obesity is associated with incident atrial fibrillation independent of gender: A meta‐analysis , 2018, Journal of cardiovascular electrophysiology.
[35] Emmanuel Stamatakis,et al. How does light-intensity physical activity associate with adult cardiometabolic health and mortality? Systematic review with meta-analysis of experimental and observational studies , 2018, British Journal of Sports Medicine.
[36] P. Östergren,et al. Reducing health inequalities with interventions targeting behavioral factors among individuals with low levels of education - A rapid review , 2018, PloS one.
[37] L. Caulfield,et al. Healthy Plant-Based Diets Are Associated with Lower Risk of All-Cause Mortality in US Adults. , 2018, The Journal of nutrition.
[38] James Woodcock,et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis , 2018, European Journal of Epidemiology.
[39] Francesca N. Delling,et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.
[40] W. Kraus,et al. Moderate‐to‐Vigorous Physical Activity and All‐Cause Mortality: Do Bouts Matter? , 2018, Journal of the American Heart Association.
[41] Steven Shea,et al. Basic vs More Complex Definitions of Family History in the Prediction of Coronary Heart Disease: The Multi‐Ethnic Study of Atherosclerosis , 2018, Mayo Clinic proceedings.
[42] R. Brook,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.
[43] Jiang He,et al. Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients , 2018, Annals of Internal Medicine.
[44] R. Guthrie. Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.
[45] Daniel W. Jones,et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline , 2018, Circulation.
[46] Deepak L. Bhatt,et al. Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. , 2017, Journal of the American College of Cardiology.
[47] Michael D. Garber,et al. Routine Assessment and Promotion of Physical Activity in Healthcare Settings: A Scientific Statement From the American Heart Association , 2018, Circulation.
[48] Guijing Wang,et al. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review , 2017, American journal of preventive medicine.
[49] M. Budoff,et al. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis , 2017, JAMA cardiology.
[50] C. Yancy,et al. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association , 2017, Circulation.
[51] E. Wan,et al. Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study , 2017, Diabetes Care.
[52] A. Avenell,et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis , 2017, British Medical Journal.
[53] Michael J. Zaleha,et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. , 2017, Lancet.
[54] Craig M. Hales,et al. Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. , 2017, NCHS data brief.
[55] L. Goldman,et al. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke , 2017, Circulation.
[56] A. Verma,et al. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines , 2017, Circulation. Cardiovascular quality and outcomes.
[57] M. Zawistowski,et al. The Veterans Affairs Cardiac Risk Score: Recalibrating the Atherosclerotic Cardiovascular Disease Score for Applied Use , 2017, Medical care.
[58] O. Franco,et al. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies , 2017, JAMA cardiology.
[59] S. Griffin,et al. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes , 2017, Diabetologia.
[60] M. Budoff,et al. The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies: A Systematic Review and Meta-Analysis. , 2017, JACC. Cardiovascular imaging.
[61] H. Krumholz. Treatment of Cholesterol in 2017. , 2017, JAMA.
[62] L. Shaw,et al. Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis. , 2017, JACC. Cardiovascular imaging.
[63] Susan Redline,et al. Insomnia and Risk of Cardiovascular Disease. , 2017, Chest.
[64] J. Manson,et al. Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults. , 2017, Journal of the American College of Cardiology.
[65] Mathew G. Wilson,et al. Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile , 2017, Circulation.
[66] P. Whelton,et al. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.
[67] Carrie D. Patnode,et al. Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force , 2017, JAMA.
[68] S. Gabriel,et al. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries , 2017, Rheumatology.
[69] Jeannie K. Lee,et al. Impact of Diabetes Care by Pharmacists as Part of Health Care Team in Ambulatory Settings: A Systematic Review and Meta-analysis , 2017, The Annals of pharmacotherapy.
[70] S. Bangalore,et al. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. , 2017, The American journal of medicine.
[71] Tamar S. Polonsky,et al. Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York , 2017, JAMA cardiology.
[72] J. Lima,et al. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study , 2017, JAMA cardiology.
[73] D. Alley,et al. Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool , 2017 .
[74] J. Hartikainen,et al. Association of objectively measured sedentary behaviour and physical activity with cardiovascular disease risk , 2017, European journal of preventive cardiology.
[75] P. Whelton,et al. Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment. , 2017, Journal of the American College of Cardiology.
[76] Yiming Zhao,et al. Lower Extremity Peripheral Arterial Disease Is an Independent Predictor of Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus in China , 2017, International journal of endocrinology.
[77] J. Attia,et al. Effects of education and income on cardiovascular outcomes: A systematic review and meta-analysis , 2017, European journal of preventive cardiology.
[78] M. Golzarand,et al. The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults , 2017, Surgical Endoscopy.
[79] C. Lewis,et al. Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death , 2017, JAMA cardiology.
[80] M. McCullough,et al. Paleolithic and Mediterranean Diet Pattern Scores Are Inversely Associated with All-Cause and Cause-Specific Mortality in Adults. , 2017, The Journal of nutrition.
[81] V. Fuster,et al. Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort. , 2017, The American journal of cardiology.
[82] D. Mozaffarian,et al. Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States , 2017, JAMA.
[83] J. Gornbein,et al. Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk , 2017, JAMA cardiology.
[84] D. Goff,et al. Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status , 2017, Journal of the American Heart Association.
[85] D. Lloyd‐Jones,et al. Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention , 2017, Hypertension.
[86] Paige L. Williams,et al. Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women , 2017, Circulation.
[87] G. Lippi,et al. Statins for Primary Prevention of Cardiovascular Disease. , 2017, Trends in pharmacological sciences.
[88] Raimund Erbel,et al. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines. , 2017, JACC. Cardiovascular imaging.
[89] J. Rehm,et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. , 2017, The Lancet. Public health.
[90] Seth A. Berkowitz,et al. Addressing Unmet Basic Resource Needs as Part of Chronic Cardiometabolic Disease Management , 2017, JAMA internal medicine.
[91] Richard D Moore,et al. Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems , 2017, JAMA cardiology.
[92] C. Chew‐Graham,et al. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis , 2017, Circulation. Cardiovascular quality and outcomes.
[93] Andy McEwen,et al. National guidelines for smoking cessation in primary care: a literature review and evidence analysis , 2017, npj Primary Care Respiratory Medicine.
[94] J. Lee,et al. Assessment of Coronary Artery Calcium Scoring for Statin Treatment Strategy according to ACC/AHA Guidelines in Asymptomatic Korean Adults , 2016, Yonsei medical journal.
[95] E. Falk,et al. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study , 2016, European heart journal.
[96] Gediminas Adomavicius,et al. Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record Data , 2016, Journal of the American Heart Association.
[97] Richard A. Kronmal,et al. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort , 2016, European heart journal.
[98] P. Venugopal,et al. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment , 2017 .
[99] Laura Lovato,et al. Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study , 2016, American Journal of Nephrology.
[100] M. Woodward,et al. Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis , 2016, Journal of Epidemiology & Community Health.
[101] N. Reichek,et al. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study. , 2016, Atherosclerosis.
[102] L. Groop,et al. Sweetened beverage intake and risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes. , 2016, European journal of endocrinology.
[103] E. Arias,et al. Mortality in the United States, 2015. , 2016, NCHS data brief.
[104] A. Kengne,et al. Built Environment, Selected Risk Factors and Major Cardiovascular Disease Outcomes: A Systematic Review , 2016, PloS one.
[105] O. Franco,et al. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. , 2016, JAMA.
[106] Yuling Hong,et al. Heart Disease and Cancer Deaths — Trends and Projections in the United States, 1969–2020 , 2016, Preventing chronic disease.
[107] D. Angiolillo,et al. Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus , 2016, Circulation.
[108] Douglas K Owens,et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.
[109] A. Schuler,et al. Cost-effectiveness of Intensive Blood Pressure Management. , 2016, JAMA cardiology.
[110] G. Francis,et al. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. , 2016, The Canadian journal of cardiology.
[111] A. Hoes,et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.
[112] P. Greenland,et al. Refining Statin Prescribing in Lower-Risk Individuals: Informing Risk/Benefit Decisions. , 2016, Journal of the American College of Cardiology.
[113] Mingyang Song,et al. Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality. , 2016, JAMA internal medicine.
[114] Jeffrey S. Gonzalez,et al. Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. , 2016, The American psychologist.
[115] Xueli Yang,et al. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) , 2016, Circulation.
[116] Brian A Ference,et al. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. , 2016, JAMA.
[117] Marie-France Hivert,et al. Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association , 2016, Circulation.
[118] Lawrence A Leiter,et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2016, The New England journal of medicine.
[119] L. Räber,et al. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes , 2016, Circulation.
[120] G. Reboldi,et al. More Versus Less Intensive Blood Pressure–Lowering StrategyNovelty and Significance , 2016 .
[121] Nia Roberts,et al. Quantifying the Association Between Physical Activity and Cardiovascular Disease and Diabetes: A Systematic Review and Meta‐Analysis , 2016, Journal of the American Heart Association.
[122] V. Fuster,et al. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. , 2016, Journal of the American College of Cardiology.
[123] John Everett Mumford,et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013 , 2016, British Medical Journal.
[124] P. Rothwell,et al. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies , 2016, PloS one.
[125] W. Hart-Davidson,et al. Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program , 2016, BMC Health Services Research.
[126] J. Manson,et al. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment. , 2016, JAMA internal medicine.
[127] J. Manson,et al. Association of Specific Dietary Fats With Total and Cause-Specific Mortality. , 2016, JAMA internal medicine.
[128] N. Stone,et al. The ABCDs of Lifestyle Counseling. , 2016, JAMA cardiology.
[129] P. Zhang,et al. Prevalence of Central Obesity among Adults with Normal BMI and Its Association with Metabolic Diseases in Northeast China , 2016, PloS one.
[130] M. Landray,et al. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. , 2016, The lancet. Diabetes & endocrinology.
[131] J. Kastelein,et al. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality. , 2016, Journal of the American College of Cardiology.
[132] D. Lloyd‐Jones,et al. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype , 2016, Circulation.
[133] B. Zee,et al. Prospective Association between Diabetic Retinopathy and Cardiovascular Disease-A Systematic Review and Meta-analysis of Cohort Studies. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[134] R. Plodkowski,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[135] E. Whitlock,et al. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.
[136] E. Whitlock,et al. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.
[137] N. Benowitz,et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial , 2016, The Lancet.
[138] A. Bhatnagar. Cardiovascular Perspective of the Promises and Perils of E-Cigarettes. , 2016, Circulation research.
[139] J. Danesh,et al. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. , 2016, Journal of the American College of Cardiology.
[140] P. Loprinzi,et al. Predictive Validity of the American College of Cardiology/American Heart Association Pooled Cohort Equations in Predicting All-Cause and Cardiovascular Disease-Specific Mortality in a National Prospective Cohort Study of Adults in the United States. , 2016, Mayo Clinic proceedings.
[141] S. Adar,et al. Neighborhood Environments and Incident Hypertension in the Multi-Ethnic Study of Atherosclerosis. , 2016, American journal of epidemiology.
[142] Sue Hee Sung,et al. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. , 2016, Journal of the American College of Cardiology.
[143] W. Maziak,et al. A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations. , 2016, Mayo Clinic proceedings.
[144] J. Bosch,et al. Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease. , 2016, The American journal of medicine.
[145] R. F. Walsh,et al. Team-Based Hypertension Management to Improve Blood Pressure Control , 2016, Journal of primary care & community health.
[146] J. Cigarroa,et al. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Circulation.
[147] S. Yusuf,et al. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.
[148] S. Yusuf,et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.
[149] G. Parati,et al. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials , 2016, Journal of hypertension.
[150] Linnea A. Polgreen,et al. Evaluation of Pharmacists' Work in a Physician‐Pharmacist Collaborative Model for the Management of Hypertension , 2016, Pharmacotherapy.
[151] L. Banks,et al. The Acute Risks of Exercise in Apparently Healthy Adults and Relevance for Prevention of Cardiovascular Events. , 2016, The Canadian journal of cardiology.
[152] M. Fischereder,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.
[153] R. Kronmal,et al. Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2016, Circulation.
[154] L. Køber,et al. Normal-Weight Central Obesity and Mortality Risk in Older Adults With Coronary Artery Disease. , 2016, Mayo Clinic proceedings.
[155] G. Biondi‐Zoccai,et al. Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis. , 2016, Progress in cardiovascular diseases.
[156] P. Ridker,et al. Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents. , 2016, European heart journal.
[157] Bo Carlberg,et al. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses , 2016 .
[158] Xiaohui Guo,et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. , 2016, The lancet. Diabetes & endocrinology.
[159] N. Smart,et al. Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit , 2016, Hypertension Research.
[160] M. Woodward,et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.
[161] J. Prochaska,et al. The Past, Present, and Future of Nicotine Addiction Therapy. , 2016, Annual Review of Medicine.
[162] L. Afonso,et al. Data on coronary artery calcium score performance and cardiovascular risk reclassification across gender and ethnicities , 2016, Data in brief.
[163] D. Mozaffarian. Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.
[164] R. Hu,et al. Cigarette Smoking and Electronic Cigarettes Use: A Meta-Analysis , 2016, International journal of environmental research and public health.
[165] Thomas R Fanshawe,et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. , 2016, The Cochrane database of systematic reviews.
[166] F. Porzsolt,et al. Using machine learning to predict laboratory test results , 2016, Annals of clinical biochemistry.
[167] C. Escobar Cervantes,et al. [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.
[168] A. Hoes,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.
[169] Jennifer Y. Liu,et al. Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events , 2016, Journal of General Internal Medicine.
[170] E. Falk,et al. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy. , 2015, Journal of the American College of Cardiology.
[171] D. Goff,et al. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial. , 2015, Hypertension.
[172] Yu Xu,et al. Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis. , 2015, International journal of cardiology.
[173] F. Hu,et al. Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review , 2015, Circulation.
[174] C. Ayers,et al. Dose–Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis , 2015, Circulation.
[175] I. Mühlhauser,et al. Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial , 2015, BMJ Open.
[176] W. Qureshi,et al. Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium , 2015, Current Cardiology Reports.
[177] R. Kronmal,et al. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). , 2015, Journal of the American College of Cardiology.
[178] Harlan M. Krumholz,et al. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). , 2015, Journal of the American College of Cardiology.
[179] D. Goff,et al. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines , 2015, Circulation.
[180] Sung Hee Choi,et al. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease. , 2015, Atherosclerosis.
[181] Jillian T Henderson,et al. Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.
[182] J. Shikany,et al. Southern Dietary Pattern Is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2015, Circulation.
[183] George Davey-Smith,et al. Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2015, Circulation.
[184] P. O'Malley,et al. Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline , 2015, Annals of Internal Medicine.
[185] Milton C Weinstein,et al. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. , 2015, JAMA.
[186] R. D'Agostino,et al. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. , 2015, JAMA.
[187] D. Harvey,et al. The risk and burden of smoking related heart disease mortality among young people in the United States , 2015, Tobacco induced diseases.
[188] G. Grandes,et al. Effectiveness of physical activity promotion interventions in primary care: A review of reviews. , 2015, Preventive medicine.
[189] G. Filippatos,et al. Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking. , 2015, Circulation. Heart failure.
[190] Dorothea K. Vafiadis,et al. The National Physical Activity Plan: A Call to Action From the American Heart Association A Science Advisory From the American Heart Association , 2015, Circulation.
[191] Jane A. Linderbaum,et al. 2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice Providers. , 2015, Journal of the American College of Cardiology.
[192] L. Goldman,et al. Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States , 2015, Annals of Internal Medicine.
[193] A. Peters,et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium , 2015, BMJ : British Medical Journal.
[194] P. Wilson,et al. Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines. , 2015, Journal of the American College of Cardiology.
[195] S. Selph,et al. Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation , 2015 .
[196] Danielle M. Enserro,et al. Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framingham Heart Study Offspring Cohort , 2015, Journal of the American Heart Association.
[197] T. Callister,et al. A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals. , 2015, JACC. Cardiovascular imaging.
[198] John W McEvoy,et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. , 2015, Annals of internal medicine.
[199] K. Rahimi,et al. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.
[200] M. Woodward,et al. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. , 2015, Annals of internal medicine.
[201] M. Szklo,et al. Social engagement and chronic disease risk behaviors: the Multi-Ethnic Study of Atherosclerosis. , 2015, Preventive medicine.
[202] Andrew E Moran,et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. , 2015, The New England journal of medicine.
[203] D. Alter,et al. Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults , 2015, Annals of Internal Medicine.
[204] K. Shimada,et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial. , 2014, JAMA.
[205] G. Parati,et al. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.
[206] N. Cook,et al. Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study. , 2014, JAMA internal medicine.
[207] J. Wilding,et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.
[208] Yongping Xu,et al. Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis , 2014, European Journal of Clinical Nutrition.
[209] K. Ethier,et al. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. , 2014, MMWR supplements.
[210] M. Budoff,et al. Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the Multi-Ethnic Study of Atherosclerosis). , 2014, The American journal of cardiology.
[211] D. Goff,et al. Electronic Cigarettes: A Policy Statement From the American Heart Association , 2014, Circulation.
[212] D. Goff,et al. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. , 2014, Journal of the American College of Cardiology.
[213] F. Kronenberg,et al. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. , 2014, Journal of the American College of Cardiology.
[214] C. Mangione,et al. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. , 2014, Clinical therapeutics.
[215] M. Woodward,et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.
[216] Majid Ezzati,et al. Global sodium consumption and death from cardiovascular causes. , 2014, The New England journal of medicine.
[217] I. Piña,et al. Status of Cardiovascular Disease and Stroke in Hispanics/Latinos in the United States: A Science Advisory From the American Heart Association , 2014, Circulation.
[218] S. de Lusignan,et al. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus , 2014, Heart.
[219] R. de Caterina,et al. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis. , 2014, Journal of the American College of Cardiology.
[220] R. Lamuela-Raventós,et al. A provegetarian food pattern and reduction in total mortality in the Prevención con Dieta Mediterránea (PREDIMED) study. , 2014, The American journal of clinical nutrition.
[221] Anilkrishna B. Thota,et al. Team-based care and improved blood pressure control: a community guide systematic review. , 2014, American journal of preventive medicine.
[222] Robert F Kushner,et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.
[223] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[224] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[225] G. Fonarow,et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Circulation.
[226] A. Subar,et al. Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. , 2014, The Journal of nutrition.
[227] S. Tsimikas,et al. The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies. , 2014, Journal of the American College of Cardiology.
[228] M. Budoff,et al. Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis , 2014, Circulation. Cardiovascular quality and outcomes.
[229] A. Bauman,et al. Review of the epidemiological evidence for physical activity and health from low- and middle-income countries , 2014, Global public health.
[230] Adam T. Perzynski,et al. Effectiveness and Safety of Patient Activation Interventions for Adults with Type 2 Diabetes: Systematic Review, Meta-Analysis, and Meta-regression , 2014, Journal of General Internal Medicine.
[231] O. Franco,et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. , 2014, JAMA.
[232] Mary Cushman,et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. , 2014, JAMA.
[233] M. Grandner. Addressing sleep disturbances: An opportunity to prevent cardiometabolic disease? , 2014, International review of psychiatry.
[234] F. Hu,et al. Added sugar intake and cardiovascular diseases mortality among US adults. , 2014, JAMA internal medicine.
[235] Jbs Board. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) , 2014, Heart.
[236] J. Cutler,et al. Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial , 2014, Diabetes Care.
[237] N. Smart,et al. Isometric exercise training for blood pressure management: a systematic review and meta-analysis. , 2014, Mayo Clinic proceedings.
[238] Juned Siddique,et al. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. , 2014, JAMA.
[239] P. Whelton,et al. Health effects of sodium and potassium in humans , 2014, Current opinion in lipidology.
[240] G. Lippi,et al. E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism , 2013, Seminars in Thrombosis & Hemostasis.
[241] M. Szklo,et al. Heart Disease in Patients With a Zero Coronary Artery Calcium Score (from the Multi-Ethnic Study of Atherosclerosis) , 2014 .
[242] B. Lushniak,et al. The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .
[243] S. Yanovski,et al. Long-term drug treatment for obesity: a systematic and clinical review. , 2014, JAMA.
[244] L. Shaw,et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[245] W. Willett,et al. Association of nut consumption with total and cause-specific mortality. , 2013, The New England journal of medicine.
[246] J. Saavedra,et al. Effects of exercise on resting blood pressure in obese children: a meta‐analysis of randomized controlled trials , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[247] José Agustín Arguedas,et al. Blood pressure targets for hypertension in people with diabetes mellitus. , 2013, The Cochrane database of systematic reviews.
[248] R. Warren,et al. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. , 2013, The Journal of investigative dermatology.
[249] S. Gudbjörnsdottir,et al. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register , 2013, Diabetes & vascular disease research.
[250] H. Tighiouart,et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.
[251] J. Manson,et al. Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. , 2013, JAMA internal medicine.
[252] Scott B Going,et al. Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women's Health Initiative. , 2013, Journal of the American College of Cardiology.
[253] V. Beral,et al. Coronary heart disease incidence in women by waist circumference within categories of body mass index , 2013, European journal of preventive cardiology.
[254] K. Lavoie,et al. The evolution of a Canadian Hypertension Education Program recommendation: the impact of resistance training on resting blood pressure in adults as an example. , 2013, The Canadian journal of cardiology.
[255] M. Ernst,et al. Physician‐Pharmacist Co‐Management and 24‐Hour Blood Pressure Control , 2013, Journal of clinical hypertension.
[256] Yue Cao,et al. Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. , 2013, The American journal of clinical nutrition.
[257] S. Lai,et al. Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease , 2013, Diabetes Care.
[258] Lee Hooper,et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.
[259] P. Elliott,et al. Effect of lower sodium intake on health: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.
[260] G. MacGregor,et al. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials , 2013, BMJ : British Medical Journal.
[261] K. Knutson. Sociodemographic and cultural determinants of sleep deficiency: implications for cardiometabolic disease risk. , 2013, Social science & medicine.
[262] V. Cornelissen,et al. Exercise Training for Blood Pressure: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.
[263] A. Goto,et al. Low-Carbohydrate Diets and All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies , 2013, PloS one.
[264] Prabhat Jha,et al. 21st-century hazards of smoking and benefits of cessation in the United States. , 2013, The New England journal of medicine.
[265] W. Alpert. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes , 2013 .
[266] Michael D. Jensen,et al. Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. , 2013, Journal of the American Pharmacists Association : JAPhA.
[267] Deepak L. Bhatt,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.
[268] M. Postma,et al. Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients , 2012, Drugs.
[269] Lihui Zhao,et al. Lifetime risk and years lived free of total cardiovascular disease. , 2012, JAMA.
[270] David M Herrington,et al. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis , 2012, Menopause.
[271] M. Woodward,et al. Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. , 2012, Diabetes research and clinical practice.
[272] U. Nöthlings,et al. Dietary Fiber, Carbohydrate Quality and Quantity, and Mortality Risk of Individuals with Diabetes Mellitus , 2012, PloS one.
[273] R. Collins,et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.
[274] S. Blair,et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy , 2012, BDJ.
[275] M. Dowda,et al. Independent Association of Waist Circumference With Hypertension and Diabetes in African American Women, South Carolina, 2007–2009 , 2012, Preventing chronic disease.
[276] Edward H Ip,et al. Lifestyle change and mobility in obese adults with type 2 diabetes. , 2012, The New England journal of medicine.
[277] S. Sutton,et al. Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials , 2012, BMJ : British Medical Journal.
[278] N. Wong,et al. Global cardiovascular disease risk assessment in United States adults with diabetes , 2012, Diabetes & vascular disease research.
[279] B. Gersh. Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis , 2012 .
[280] M. Burtscher. Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.
[281] G. Jürgens,et al. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). , 2012, American journal of hypertension.
[282] J. Pell,et al. Meta-analysis of the association between secondhand smoke exposure and stroke. , 2011, Journal of public health.
[283] A. Kengne,et al. Body mass index, waist circumference and waist–hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual‐participant meta‐analysis of 82 864 participants from nine cohort studies , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[284] Lora E Burke,et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. , 2011, Circulation.
[285] I-Min Lee,et al. Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis , 2011, Circulation.
[286] D. Roter,et al. A Randomized Trial to Improve Patient-Centered Care and Hypertension Control in Underserved Primary Care Patients , 2011, Journal of General Internal Medicine.
[287] G. Mancia,et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients , 2011, Journal of hypertension.
[288] David M. Eddy,et al. Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs , 2011, Annals of Internal Medicine.
[289] C. Furberg,et al. A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk , 2011, Circulation. Cardiovascular quality and outcomes.
[290] Amy Earley,et al. Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier , 2011, Annals of Internal Medicine.
[291] K. Reynolds,et al. Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension: A Meta-Analysis , 2012 .
[292] M. Woodward,et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials , 2011, Journal of hypertension.
[293] M. Taskinen,et al. [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.
[294] Neil M. Johannsen,et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. , 2010, JAMA.
[295] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.
[296] A. Khera,et al. Body size misperception: a novel determinant in the obesity epidemic. , 2010, Archives of internal medicine.
[297] L. Diep,et al. Association of physical activity level and stroke outcomes in men and women: a meta-analysis. , 2010, Journal of women's health.
[298] A. Tonkin,et al. Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[299] J. Graff Zivin,et al. US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses , 2010, Medical care.
[300] W. Willett,et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients , 2010, Diabetes Care.
[301] Keith C. Norris,et al. Intensive blood-pressure control in hypertensive chronic kidney disease. , 2010, The New England journal of medicine.
[302] R. Palmer,et al. Participatory Decision Making, Patient Activation, Medication Adherence, and Intermediate Clinical Outcomes in Type 2 Diabetes: A STARNet Study , 2010, The Annals of Family Medicine.
[303] JoAnn E. Manson,et al. Coronary Heart Disease Major Dietary Protein Sources and Risk of Coronary Heart Disease in Women , 2017 .
[304] D. Hessler,et al. Using the Teamlet Model to Improve Chronic Care in an Academic Primary Care Practice , 2010, Journal of General Internal Medicine.
[305] Robert J Glynn,et al. Body mass index, waist circumference, and risk of coronary heart disease: A prospective study among men and women. , 2010, Obesity research & clinical practice.
[306] Mary Cushman,et al. Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.
[307] Dariush Mozaffarian,et al. Red and Processed Meat Consumption and Risk of Incident Coronary Heart Disease, Stroke, and Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2010, Circulation.
[308] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[309] P. Sandercock,et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. , 2010, JAMA.
[310] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[311] P. Lin,et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. , 2010, Archives of internal medicine.
[312] Michael E. Miller,et al. ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES , 2010 .
[313] Karin Kraft,et al. [Type-2 diabetes]. , 2010, MMW Fortschritte der Medizin.
[314] Shimin Zheng,et al. The potency of team-based care interventions for hypertension: a meta-analysis. , 2009, Archives of internal medicine.
[315] Nancy K Latham,et al. Progressive resistance strength training for improving physical function in older adults. , 2009, The Cochrane database of systematic reviews.
[316] Michael J. Pencina,et al. Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.
[317] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[318] N. Sattar,et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.
[319] N J Wald,et al. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.
[320] D. Mozaffarian,et al. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes , 2009, Nature Reviews Endocrinology.
[321] G. Boysen,et al. European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.
[322] K. Winkley,et al. An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and generalist clinicians on glycaemic control and on psychological status. , 2009, Patient education and counseling.
[323] D. Mozaffarian,et al. The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors , 2009, PLoS medicine.
[324] Nicola Orsini,et al. Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis , 2009, European Journal of Epidemiology.
[325] R. Collins,et al. Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels , 2009, Circulation. Cardiovascular quality and outcomes.
[326] Grant D. Huang,et al. Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.
[327] N. Grossblatt. Secondhand Smoke Exposure and Cardiovascular Effects : Making Sense of the Evidence , 2009 .
[328] F. McAlister,et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). , 2008, Archives of internal medicine.
[329] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[330] T. Morimoto,et al. Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes , 2012 .
[331] J. Witteman,et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.
[332] N. Paynter,et al. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.
[333] P. Macfarlane,et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease , 2008, BMJ : British Medical Journal.
[334] P. Miller,et al. Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. , 2008, Addiction.
[335] Daniel Touchette,et al. A Randomized Controlled Trial of Team-Based Care: Impact of Physician-Pharmacist Collaboration on Uncontrolled Hypertension , 2008, Journal of General Internal Medicine.
[336] R. R. Wolfe,et al. The danger of weight loss in the elderly , 2008, The journal of nutrition, health & aging.
[337] M. Böhm,et al. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League , 2008, Journal of hypertension.
[338] S. Soedamah-Muthu,et al. Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database , 2008, Diabetologia.
[339] Rosanna Abbate,et al. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[340] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[341] E. Michelson,et al. TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension. , 2008, Journal of the American Society of Hypertension : JASH.
[342] M. Hamer,et al. Walking and primary prevention: a meta-analysis of prospective cohort studies , 2007, British Journal of Sports Medicine.
[343] D. Coyle,et al. Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes , 2007, Annals of Internal Medicine.
[344] S. Kalra,et al. EXERCISE AND ACUTE CARDIOVASCULAR EVENTS: PLACING THE RISKS INTO PERSPECTIVE: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION COUNCIL ON NUTRITION, PHYSICAL ACTIVITY, AND METABOLISM AND THE COUNCIL ON CLINICAL CARDIOLOGY , 2007 .
[345] A. Trichopoulou,et al. Low-carbohydrate–high-protein diet and long-term survival in a general population cohort , 2007, European Journal of Clinical Nutrition.
[346] N. Cook,et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) , 2007, BMJ : British Medical Journal.
[347] Will G. Hopkins,et al. Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis , 2007, Diabetes Care.
[348] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[349] W. Hopkins,et al. Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients , 2006, Diabetes Care.
[350] D. Mikhailidis,et al. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) , 2006, Diabetes Care.
[351] Yasuo Ohashi,et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial , 2006, The Lancet.
[352] L. Pbert,et al. Smoking Prevention and Cessation Intervention Delivery by Pediatric Providers, as Assessed With Patient Exit Interviews , 2006, Pediatrics.
[353] S. Yusuf,et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.
[354] S. Pocock,et al. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes , 2006, Diabetes Care.
[355] S. Oparil,et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.
[356] S. Soedamah-Muthu,et al. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. , 2006, Diabetes care.
[357] Ralph B D'Agostino,et al. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.
[358] Bryan Williams,et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials , 2006, Journal of hypertension.
[359] C. Samuel-Hodge,et al. Achieving healthy weight in African-American communities: research perspectives and priorities. , 2005, Obesity research.
[360] S. Kritchevsky,et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. , 2005, The American journal of clinical nutrition.
[361] R. Collins,et al. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). , 2005, Diabetes care.
[362] T. Harris,et al. Health consequences of obesity in the elderly: a review of four unresolved questions , 2005, International Journal of Obesity.
[363] F. Gueyffier,et al. Treatment of High Blood Pressure and Gain in Event-Free Life Expectancy , 2005, Vascular health and risk management.
[364] B. Hedblad,et al. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the population study 'Men born in 1914' from Malmö, Sweden. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[365] J. Kaufman,et al. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review , 2005, BMC public health.
[366] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[367] S. Rabe-Hesketh,et al. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes , 2004, The Lancet.
[368] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[369] K. Lohr,et al. Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.
[370] F. Biro,et al. Different shapes in different cultures: body dissatisfaction, overweight, and obesity in African-American and caucasian females. , 2003, Journal of pediatric and adolescent gynecology.
[371] Diederick E. Grobbee,et al. Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.
[372] Lung. High blood cholesterol. , 2003, Nutrition in clinical care : an official publication of Tufts University.
[373] T. Fahey,et al. The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis , 2003, Journal of hypertension.
[374] A. Dyer,et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .
[375] Christopher H Schmid,et al. Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.
[376] D. Grobbee,et al. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials , 2003, Journal of Human Hypertension.
[377] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[378] Victor J Stevens,et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. , 2003, JAMA.
[379] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[380] M. Munafo,et al. Interventions for smoking cessation in hospitalised patients. , 2003, The Cochrane database of systematic reviews.
[381] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[382] Tom Greene,et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.
[383] D. Bennett,et al. Blood pressure and coronary heart disease: a review of the evidence. , 2002, Seminars in vascular medicine.
[384] James F Sallis,et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.
[385] Jiang He,et al. Effect of Aerobic Exercise on Blood Pressure , 2002, Annals of Internal Medicine.
[386] A. Woods. High blood pressure (hypertension). , 2002, Nursing.
[387] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[388] S. Hampson. Randomised, placebo-controlled trial , 2002 .
[389] R. Sigal,et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.
[390] G L Freeman,et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.
[391] Jiang He,et al. Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2001, Hypertension.
[392] Glen P. Kenny,et al. Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus: A Meta-analysis of Controlled Clinical Trials , 2001 .
[393] M. Yoshiyama,et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. , 2001, JAMA.
[394] G. Bray,et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.
[395] T. Lancaster,et al. Training health professionals in smoking cessation. , 2000, The Cochrane database of systematic reviews.
[396] P. Priest,et al. Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated , 2000, BMJ : British Medical Journal.
[397] Orton,et al. EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .
[399] R. Holman,et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.
[400] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[401] A. Gotto,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.
[402] P. Whelton,et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.
[403] P. Whelton,et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.
[404] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[405] R. D'Agostino,et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.
[406] N. Cook,et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. , 1997, The American journal of clinical nutrition.
[407] Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. , 1997, Archives of internal medicine.
[408] V. Nicaud,et al. Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group. , 1995, Journal of epidemiology and community health.
[409] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.
[410] C. Lewis,et al. Treatment of Mild Hypertension Study: Final Results , 1993 .
[411] J. Cutler,et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.
[412] N. Cook,et al. The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .
[413] A. Haines,et al. Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. , 1988, BMJ.
[414] M. Wiewiórowska. [Patients with diabetes mellitus]. , 1987, Pielegniarka i polozna.